Non-Executive Chairman
Across our markets, our teams continued to care for patients with professionalism and compassion, reinforcing the confidence placed in us by patients, partners and shareholders.
Dear Stakeholders,
At IHH, our responsibility extends beyond performance. It is about upholding trust, maintaining strong governance and ensuring that we continue to deliver safe, high-quality care with integrity. In FY2025, we remained focused on strengthening our foundations so that we can serve patients well today while sustaining our ability to do so for generations to come.
As a leading multinational healthcare network, our strength lies in the dedication of our healthcare professionals and the standards that define our trusted brands. Across our markets, our teams continued to care for patients with professionalism and compassion, reinforcing the confidence placed in us by patients, partners and shareholders.
The Board provided oversight and guidance to support long-term resilience and responsible growth. Through clear strategic direction and strong governance practices, we ensure that IHH remains a trusted healthcare partner across the markets we serve.
Empowering Care, Prioritising Patients
Delivering safe, high-quality and accessible care remains at the heart of our purpose, and the Board takes an active interest in how these standards are upheld across our network. During the year, the Group strengthened its clinical capabilities across key specialties, expanded complex procedure that support better patient outcomes. Digital and AI-enabled tools were introduced thoughtfully to enhance diagnostics, research and clinical decision-making.
Across several hospitals, important clinical milestones were achieved, including advanced minimally invasive cardiac procedures and the expansion of translational research capabilities. Partnerships to advance valuebased care models also progressed, reflecting our shared responsibility to balance quality care with long-term sustainability of healthcare systems.
Industry recognition further affirmed the quality and consistency of our standards. Mount Elizabeth hospitals in Singapore received 97 awards at the Singapore Health Quality Awards in January 2026, underscoring excellence in clinical governance and patient safety. Gleneagles HealthCity Chennai was honoured at the 2025 DRI International Awards of Excellence for “Response and Recovery of the Year”, reflecting operational resilience and preparedness. During the year, IHH was also included in the Fortune Southeast Asia 500 ranking. These recognitions are a testament to the dedication of our teams and their unwavering commitment and dedication to patients.
Human Capital and Leadership Development
The quality of care we provide is shaped by the dedication, professionalism and integrity of our people. In a healthcare environment where skills are specialised and highly sought after, supporting, nurturing, and retaining our workforce remains one of our most important responsibilities.
Throughout the year, the Group continued to invest in leadership development, succession planning and clinical capability building across markets. Programmes like I.GLOBE and Project Nightingale continue to play an important role to help nurture future leaders and sustain nursing excellence, initiatives that the Board views as critical to long-term organisational stability.
The IHH Learning Academy further expanded opportunities for continuous education, enabling our people to grow alongside evolving clinical practices and technologies. These efforts reflect our belief that caring for our people is essential to sustaining high standards of patient care.
As the Group progresses, preserving institutional knowledge, professionalism and a strong culture of accountability will remain a priority for the Board.
Caring for a Sustainable Tomorrow
Sustainability remains integral to our long-term strategy and risk oversight. During the year, we refreshed our targets across four key pillars, strengthening alignment between our growth ambitions and our responsibilities to Patients, People, Planet and Public.
Quality and patient safety remain foundational to our sustainability agenda. The Group continues to monitor 17 key quality indicators covering patient safety, clinical outcomes and operational effectiveness, reinforcing accountability and transparency across our network.
In advancing our climate commitments, we are working towards a 42% reduction in Scope 1 and 2 emissions, and are engaging with 70% of IHH suppliers to disclose their Scope 1 and 2 emissions. We have expanded our environmental targets to include water and waste management with a goal of achieving 30% non-hazardous waste recycling or landfill diversion rate by 2030.
Beyond environmental stewardship, we continue to strengthen responsible clinical practices. With the successful completion of phase 3 of our Antimicrobial Stewardship Programme (ASP), we will now prioritise measuring and tracking the compliance rate of our hospitals with the ASP protocols. This reinforces our commitment to combating antimicrobial resistance and safeguarding patient and public health across our markets.
Robust Governance and Leadership
The Board remains committed to upholding high standards of governance, integrity and accountability across the Group. We recognise the trust placed in us to safeguard IHH’s long-term stability and to ensure that decisions are made thoughtfully and prudently, always with our patients, people and stakeholders in mind.
Sound judgement and long-term responsibility guide the Board’s oversight, ensuring that growth remains measured and sustainable. Our governance framework is underpinned by clear policies on ethical conduct, anti-bribery and corruption, and whistleblowing, reinforcing transparency and accountability across all our markets.
Reflecting the Group’s resilient performance, the Board has declared a final cash dividend of 5.5 sen per share, bringing the total ordinary dividends for FY2025 to 10.5 sen per share, an increase from 10.0 sen per share in FY2024. This represents a payout ratio of more than 40% of PATMI, exceeding our dividend policy requirement of 30%. This balanced approach demonstrates our commitment to deliver sustainable returns while preserving financial strength to support future growth.
As we move forward, we will continue to provide independent oversight and constructive challenge to safeguard the long-term interests of our stakeholders.
Looking Ahead
The foundations strengthened in FY2025 position the Group well for the years ahead. As healthcare systems continue to evolve amid demographic shifts, technological advancement and rising expectations, IHH is well placed to respond with the depth of its clinical expertise, the strength of its network and the professionalism of its people.
The Board will continue to support management in delivering high-quality care responsibly and sustainably, ensuring that growth remains aligned with our values and aspiration to Care. For Good.
With the continued trust and confidence of our stakeholders, we are encouraged by the path ahead. Together, we will continue to strengthen IHH as a trusted healthcare network, guided by integrity and compassion, and staying true to our purpose of touching lives and transforming care.
Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani
Non-Executive Chairman
